Pritesh Shah

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

NVCR

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	NovoCure Ltd (NVCR)	Chief Commercial Officer Francis Leonard President, CNS Cancers US	$500,000	$0	$2,933,327	$1,468,561	$267,000	$11,250	$5,180,138
2022	NovoCure Ltd (NVCR)	Chief Commercial Officer Francis Leonard President, CNS Cancers US	$500,000	$0	$3,499,863	$2,006,171	$300,000	$10,599	$6,316,633
2021	NovoCure Ltd (NVCR)	Chief Commercial Officer Francis Leonard President, CNS Cancers US	$500,000	$0	$3,333,248	$1,664,746	$0	$8,900	$5,506,894
2020	NovoCure Ltd (NVCR)	Chief Commercial Officer Francis Leonard President, CNS Cancers US	$481,250	$0	$3,333,276	$1,661,147	$450,000	$14,925	$5,940,598
2019	NovoCure Ltd (NVCR)	Chief Commercial Officer	$425,000	$0	$867,982	$2,027,390	$280,500	$73,061	$3,673,933
2018	NovoCure Ltd (NVCR)	Chief Commercial Officer	$400,000	$0	$768,196	$1,616,575	$265,625	$20,100	$3,070,496

No earnings-call appearances or filed executive changes recorded yet.